CALC
CalciMedica, Inc.
There isn't enough reported data to score CALC yet.
CALC Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Under pressure | |
| Unavailable | |
| Unavailable |
CALC's profitability is currently under pressure. There isn't enough data to rate its revenue, cash flow and balance sheet.
CALC PE Valuation
CALC has no meaningful PE right now: it lost money over the past year.
CALC Forward outlook
There aren't enough analyst estimates for CALC to show an outlook.
CALC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$4.44 | +$3.81 |
| Q2 2026 | -$6.80 | +$1.35 |
| Q1 2026 | -$6.55 | +$1.40 |
| Q4 2025 | -$9.85 | -$3.75 |
| Q3 2023 | -$150.60 | -$29.50 |
| Q2 2023 | -$178.70 | -$63.20 |
| Q1 2023 | -$199.75 | -$85.65 |
| Q4 2022 | -$116.20 | +$2.10 |
CALC is still losing money, but far less than before: $4.44 per share over the past year, against $285.25 at its worst in late 2020.
CALC Quarterly Revenue
CALC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$3.9M | +$923K |
| Q2 2026 | -$4.6M | +$2.1M |
| Q1 2026 | -$4.9M | +$31K |
| Q4 2025 | -$4.9M | +$116K |
| Q3 2025 | -$4.8M | -$113K |
| Q1 2025 | -$4.9M | -$172K |
| Q4 2024 | -$5M | -$1.4M |
| Q3 2024 | -$4.7M | -$102K |
CALC has burned cash in almost every quarter: −$18M over the past year, against −$21M the year before.
CALC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +102% | +3.5M shares |
| 1 year | +129% | +3.9M shares |
| 3 years | +510% | +5.8M shares |
| 5 years | +2187% | +6.6M shares |
| Available history | +3244% | +6.7M shares |
CALC has 7M diluted shares, up 129% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2020 | — |
| Q1 2020 | — |
| Q4 2019 | — |
CALC Net Leverage
CALC's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CALC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.5 | Neutral |
| Stochastic | 9.9 | Oversold |
CALC's weekly RSI is 35 (neutral) and its Stochastic is 10 (oversold).
CALC PE vs Healthcare Sector
CALC has no meaningful PE right now: it lost money over the past year.
CALC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.37 | 11% below |
| 20 week MA | $2.55 | 52% below |
| 50 week MA | $6.96 | 82% below |
| 100 week MA | $9.80 | 88% below |
| 200 week MA | $16.4 | 93% below |
CALC is in a downtrend: it's below all five of its weekly moving averages, and 93% below its 200-week average.
CALC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $913.5 | $1,972.6 | +116% |
| 2021 | $1,972.6 | $143.5 | -93% |
| 2022 | $143.5 | $37.1 | -74% |
| 2023 | $37.1 | $14.3 | -61% |
| 2024 | $14.3 | $14.3 | -0.3% |
| 2025 | $14.3 | $31.2 | +119% |
| 2026 YTD | $31.2 | $1.22 | -96% |
CALC's yearly returns have swung widely, from +119% in 2025 to −93% in 2021. It's down 96% so far in 2026.